Off-Grid Europe offers multiple High Voltage Battery Energy Storage Systems (BESS), which can be both integrated with renewable energy sources or be standalone systems that range from 500 kWh to 10 MWh in storage and inverter load capacities to match.
These systems address the need for greater stability and flexibility in larger commercial and utility-scale applications.
Turnkey: a single enclosure is used to house the integrated battery modules, inverter, thermal management plus AC & DC componentry for fast on-site installation
Intelligent: Energy Management System software monitors and predicts energy usage to balance the consumption and power source to ensure the lowest levelised cost of energy (LCOE) possible
Scalable: These system sizes range from 500 kWh to multiple MWh range with corresponding inverters, allowing flexibility in matching the exact needs of the desired system
Compact: Can be outdoor IP67 racks or in a containerised format, with different layouts possible to suite smaller spaces
Reliable: Systems come with up to a 15 year global warranty made possible due to build quality and constant remote system monitoring
Recycable: At the end of their useful life these systems will be stripped down and core material used for future batteries
Being confronted with the strong effects of the Covid-19 pandemic in early 2020, made us want to use our technological expertise to alleviate the chronic shortage of medical oxygen often found in low- and middle-income countries, also prior to the pandemic.
The SolarO2 System consists of a fully off-grid power system, oxygen condenser and a high pressure cylinder filling pump integrated into a single plug-and play oxygen generation plant that is powered by solar energy. As the system is fully integrated and self-contained, it can be used anywhere in the world and is independent of unreliable grids and supply chains.
Improving access to oxygen and pulse oximetry (instrument used to measure blood oxygen levels) has demonstrated a reduction in mortality from childhood pneumonia by up to 35% in high-burden child pneumonia settings.